The FDA Advisory Committee decided not to approve boosters for people sixteen and up. Instead, they made a recommendation for those 65 and up, or younger people at high risk to get a booster shot right now from Pfizer-Biontech.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
Podkasten Consider This from NPR er innebygd på denne siden fra en åpen RSS feed. Alle filer, beskrivelser, illustrasjoner og andre metadata fra RSS-feeden tilhører podcasteieren og er ikke tilknyttet eller validert av Podplay.